US Patent 10568848 Treatment of autism with cannabidiol
Patent 10568848 was granted and assigned to Zynerba Pharmaceuticals on February, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
May 14, 2019
0
Date of Patent
February 25, 2020
0
Patent Applicant
Patent Application Number
16411248
0
Patent Citations Received
Patent Inventor Names
Donna Gutterman
0
Marcel Bonn-Miller
0
Terri Sebree
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10568848 Treatment of autism with cannabidiol
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
